Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy

Pregnancy is associated with an increased risk of venous thromboembolism (VTE). Previous VTE and severe thrombophilia are important risk factors. Our case was a 36-year-old woman, gravida 6, para 0, with antithrombin (AT) deficiency caused by a homozygous mutation in the heparin-binding site (HBS)....

Descripción completa

Detalles Bibliográficos
Autores principales: Fiskvik, Hilde, Jacobsen, Anne F., Iversen, Nina, Henriksson, Carola E., Jacobsen, Eva-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433018/
https://www.ncbi.nlm.nih.gov/pubmed/34513101
http://dx.doi.org/10.1155/2021/4393821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433018/
https://www.ncbi.nlm.nih.gov/pubmed/34513101
http://dx.doi.org/10.1155/2021/4393821

Ejemplares similares